Skip to main content

Charles Douglas Scales Jr., MD, MSHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Office: 40 Medicine Circle, Duke South, White Zone, Suite 1570, Durham, NC 27707
Campus Mail: DUMC DUMC 3707, Durham, NC 27710

Education and Training

  • Robert Wood Johnson Foundatin/VA Scholar, University of California, School of Medicine, 2011 - 2013
  • Resident, Urology, Duke University, 2006 - 2011
  • Intern, Surgery, Duke University, 2005 - 2006
  • Research Associate, Urology, Duke University, 2004 - 2005
  • M.D., Duke University School of Medicine, 2004

Publications

Scales, Charles D., Alana C. Desai, Jonathan D. Harper, H Henry Lai, Naim M. Maalouf, Peter P. Reese, Gregory E. Tasian, et al. “Prevention of Urinary Stones With Hydration (PUSH): Design and Rationale of a Clinical Trial.” Am J Kidney Dis 77, no. 6 (June 2021): 898-906.e1. https://doi.org/10.1053/j.ajkd.2020.09.016.

Full Text

Wong, Charlene A., William B. Song, Megan Jiao, Emily O’Brien, Peter Ubel, Gary Wang, and Charles D. Scales. “Strategies for research participant engagement: A synthetic review and conceptual framework.” Clin Trials, May 20, 2021, 17407745211011068. https://doi.org/10.1177/17407745211011068.

Full Text

Urinary Stone Disease Research Network (USDRN) Investigators, J. M. “Impact of COVID-19 on Prevention of Urinary Stones with Hydration (PUSH) Study: Challenges and Opportunities for Future Trials.” J Urol, April 28, 2021, 101097JU0000000000001833. https://doi.org/10.1097/JU.0000000000001833.

Full Text

Jang, David W., Hui Jie Lee, Philip G. Chen, Seth M. Cohen, and Charles D. Scales. “Geographic Variations in Healthcare Utilization and Expenditure for Chronic Rhinosinusitis: A Population-Based Approach.” Laryngoscope, April 27, 2021. https://doi.org/10.1002/lary.29588.

Full Text

Schoenfeld, Elizabeth M., Kye E. Poronsky, Lauren M. Westafer, Brianna M. DiFronzo, Paul Visintainer, Charles D. Scales, Erik P. Hess, and Peter K. Lindenauer. “Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial.” Trials 22, no. 1 (March 10, 2021): 201. https://doi.org/10.1186/s13063-021-05140-9.

Full Text

Dinan, Michaela A., Mihaela V. Georgieva, Yanhong Li, Tian Zhang, Michael Harrison, Rahul Shenolikar, and Charles D. Scales. “Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012.” J Geriatr Oncol 12, no. 2 (March 2021): 298–304. https://doi.org/10.1016/j.jgo.2020.08.005.

Full Text

Dinan, Michaela Ann, Lauren E. Wilson, Melissa A. Greiner, Lisa Spees, Jessica Pritchard, Tian Zhang, Deborah Kaye, Daniel J. George, Charles D. Scales, and Stephanie B. Wheeler. “Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).” In Journal of Clinical Oncology, 39:280–280. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.6_suppl.280.

Full Text

Wheeler, Stephanie B., Lisa Spees, Bradford E. Jackson, Christopher Baggett, Lauren E. Wilson, Melissa A. Greiner, Daniel J. George, Charles D. Scales, Jessica Pritchard, and Michaela Ann Dinan. “Patterns and predictors of oral anticancer agent utilization in diverse metastatic renal cell carcinoma patients.” In Journal of Clinical Oncology, 39:279–279. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.6_suppl.279.

Full Text

Dionise, Zachary R., Juan Marcos Gonzalez, Michael L. Garcia-Roig, Andrew J. Kirsch, Charles D. Scales, John S. Wiener, J Todd Purves, and Jonathan C. Routh. “Parental preferences for vesicoureteral reflux treatment: Profile case best-worst scaling.” J Pediatr Urol 17, no. 1 (February 2021): 86.e1-86.e9. https://doi.org/10.1016/j.jpurol.2020.11.020.

Full Text

Scales, Charles D., H Henry Lai, Alana C. Desai, Jodi A. Antonelli, Naim M. Maalouf, Gregory E. Tasian, Peter P. Reese, et al. “Study to Enhance Understanding of Stent-Associated Symptoms: Rationale and Study Design.” J Endourol, November 16, 2020. https://doi.org/10.1089/end.2020.0776.

Full Text

Pages